140. Dorabe syndrome Clinical trials / Disease details

Clinical trials : 116 / Drugs : 65 - (DrugBank : 17) / Drug target genes : 50 - Drug target pathways : 64

diseases per page:

Showing 1 to 10 of 116 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05485831 (ClinicalTrials.gov)	April 2023	29/7/2022	Epidyolex® in Lennox Gastaut and Dravet Syndrome: an Observational Study in ITALY	Observational, Prospective, Multicenter Study of Epidyolex® (Cannabidiol CBD 100 mg/ml) Oral Solutio ...	Lennox Gastaut Syndrome;Dravet Syndrome	Drug: Epidiolex 100 mg/mL Oral Solution	Jazz Pharmaceuticals	Evidilya S.r.l.	Not yet recruiting	6 Years	17 Years	All	70		Italy
2	NCT05560282 (ClinicalTrials.gov)	December 10, 2022	26/9/2022	Fenfluramine for Adult Dravet Patients	Fenfluramine for the Treatment of Refractory Epilepsy in Adult Dravet Patients	Dravet Syndrome;Dravet Syndrome, Intractable	Drug: Fenfluramine	University Health Network, Toronto	Zogenix, Inc.	Not yet recruiting	18 Years	N/A	All	15	Phase 3	Canada
3	NCT05419492 (ClinicalTrials.gov)	December 2022	10/6/2022	A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Po ...	ENDEAVOR: A Clinical Study to Evaluate the Safety and Efficacy of ETX101, an AAV9-Delivered Gene The ...	Dravet Syndrome	Drug: ETX101	Encoded Therapeutics	NULL	Not yet recruiting	6 Months	36 Months	All	22	Phase 1/Phase 2	NULL
4	NCT05626634 (ClinicalTrials.gov)	November 8, 2022	15/11/2022	Open-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic Encephalopa ...	A Phase 2, Multicenter, Open-label, Long-term Safety Study of LP352 in Subjects With Developmental a ...	Developmental and Epileptic Encephalopathy;Dravet Syndrome;Lennox-Gastaut Syndrome	Drug: LP352	Longboard Pharmaceuticals	NULL	Recruiting	12 Years	65 Years	All	50	Phase 2	United States
5	EUCTR2021-003425-30-ES (EUCTR)	27/07/2022	23/03/2022	A 20-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of EPX-100 (Clemizole HCl) ...	A 20-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of EPX-100 (Clemizole HCl) ...	Dravet Syndrome;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]	Product Name: EPX-100 (Clemizole Hydrochloride) Product Code: EPX-100 INN or Proposed INN: CLEMIZOLE HYD ...	Epygenix Therapeutics, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	74	Phase 2	United States;Canada;Spain;United Kingdom
6	EUCTR2021-002482-17-ES (EUCTR)	04/04/2022	20/12/2021	Open-Label Extension Study of Soticlestat in Dravet and Lennox-Gastaut Syndromes	A Phase 3, Prospective, Open-Label, Multisite, Extension of Phase 3 Studies To Assess the Long-Term ...	Dravet Syndrome(DS)Lennox-Gastaut Syndrome (LGS) MedDRA version: 20.0;Level: LLT;Classification code ...	Product Name: soticlestat Product Code: TAK-935 INN or Proposed INN: SOTICLESTAT Product Name: soticles ...	Takeda Development Center Americas, Inc	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	376	Phase 3	United States;Serbia;Greece;Spain;Ukraine;Russian Federation;Italy;France;Hungary;Canada;Belgium;Pol ...
7	EUCTR2021-002482-17-NL (EUCTR)	17/03/2022	27/12/2021	Open-Label Extension Study of Soticlestat in Dravet and Lennox-Gastaut Syndromes	A Phase 3, Prospective, Open-Label, Multisite, Extension of Phase 3 Studies To Assess the Long-Term ...	Dravet Syndrome(DS)Lennox-Gastaut Syndrome (LGS) MedDRA version: 20.0;Level: LLT;Classification code ...	Product Name: soticlestat Product Code: TAK-935 INN or Proposed INN: SOTICLESTAT Product Name: soticles ...	Takeda Development Center Americas, Inc	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	376	Phase 3	United States;Serbia;Greece;Spain;Ukraine;Russian Federation;Italy;France;Hungary;Canada;Belgium;Pol ...
8	EUCTR2021-002482-17-GR (EUCTR)	17/03/2022	24/01/2022	Open-Label Extension Study of Soticlestat in Dravet and Lennox-Gastaut Syndromes	A Phase 3, Prospective, Open-Label, Multisite, Extension of Phase 3 Studies To Assess the Long-Term ...	Dravet Syndrome(DS)Lennox-Gastaut Syndrome (LGS) MedDRA version: 20.0;Level: LLT;Classification code ...	Product Name: soticlestat Product Code: TAK-935 INN or Proposed INN: SOTICLESTAT Product Name: soticles ...	Takeda Development Center Americas, Inc	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	376	Phase 3	Serbia;United States;Greece;Spain;Ukraine;Russian Federation;Italy;France;Hungary;Canada;Poland;Belg ...
9	NCT05163314 (ClinicalTrials.gov)	March 4, 2022	15/12/2021	A Study of Soticlestat as an Add-on Therapy in Children and Adults With Dravet Syndromeor Lennox-Gas ...	A Phase 3, Prospective, Open-Label, Multisite, Extension of Phase 3 Studies To Assess the Long-Term ...	Dravet Syndrome (DS);Lennox Gastaut Syndrome (LGS)	Drug: Soticlestat	Takeda	NULL	Recruiting	2 Years	56 Years	All	376	Phase 3	United States;Australia;Belgium;Brazil;Canada;China;France;Germany;Greece;Hungary;Italy;Japan;Latvia ...
10	JPRN-jRCT2051210182	04/03/2022	02/03/2022	A Study of Soticlestat as an Add-on Therapy in Children and Adults With Dravet Syndromeor Lennox-Gas ...	A Phase 3, Prospective, Open-Label, Multisite, Extension of Phase 3 Studies To Assess the Long-Term ...	Dravet Syndrome (DS), Lennox Gastaut Syndrome (LGS)	Participants with DS and LGS will receive: Participants weighing <45 kg: Soticlestat, mini-tablets, ...	Nonomura Hidenori	NULL	Recruiting	>= 2age old	<= 36age old	Both	376	Phase 3	Australia;Belgium;Canada;China;Spain;France;United Kingdom;Greece;Hungary;Italy;Latvia;Netherlands;P ...

First Previous1 2 3 4 5…12Next Last